. Author manuscript; available in PMC: 2023 Mar 1.

Published in final edited form as: J Affect Disord. 2021 Dec 22;300:10–16. doi: 10.1016/j.jad.2021.12.055

Table 1:

Baseline demographic and clinical characteristics by treatment group (N=80)

	Midazolam (N=40), mean (SD)	Ketamine (N=40), mean (SD)
Age	40.7 (13.1)	38.4 (13.2)
Female, no. (%)	26 (65%)	22 (55%)
SSI	15.7 (6.9)	14.3 (6.3)
No of Past MDD ep, median (range)	3 (1 to "too many to count")	4.5 (1 to "too many to count")
Hx of Past Suicide Attempt at Randomization, no. (%)	22 (55)	17 (42.5)
Baseline HDRS-24	30.25 (6)	29.35 (6.2)
Baseline BDI	33.9 (8.1)	31.8 (8.1)
Baseline POMS	101.7 (35.2)	95.92 (37.4)

SSI = Beck Scale for Suicidal Ideation; MDD = Major Depressive Disorder; HDRS-24 = 24 item Hamilton Depression Rating Scale; BDI = Beck Depression inventory; POMS = Profile of Mood States